BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 17190527)

  • 1. Restarting clozapine after neutropenia: evaluating the possibilities and practicalities.
    Whiskey E; Taylor D
    CNS Drugs; 2007; 21(1):25-35. PubMed ID: 17190527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clozapine rechallenge after neutropenia in resistant schizophrenia: A review].
    Simon L; Cazard F
    Encephale; 2016 Aug; 42(4):346-53. PubMed ID: 27109327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can we prevent blood dyscrasia (leucopenia, thrombocytopenia) and epileptic seizures induced by clozapine.
    Herceg M; Muzinić L; Jukić V
    Psychiatr Danub; 2010 Mar; 22(1):85-9. PubMed ID: 20305597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clozapine rechallenge and initiation despite neutropenia- a practical, step-by-step guide.
    Silva E; Higgins M; Hammer B; Stephenson P
    BMC Psychiatry; 2020 Jun; 20(1):279. PubMed ID: 32503471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lithium and clozapine rechallenge: a retrospective case analysis.
    Kanaan RA; Kerwin RW
    J Clin Psychiatry; 2006 May; 67(5):756-60. PubMed ID: 16841625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of granulocyte-colony stimulating factor to prevent recurrent clozapine-induced neutropenia on drug rechallenge: A systematic review of the literature and clinical recommendations.
    Myles N; Myles H; Clark SR; Bird R; Siskind D
    Aust N Z J Psychiatry; 2017 Oct; 51(10):980-989. PubMed ID: 28747065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing outcomes in clozapine rechallenge following neutropenia: a cohort analysis.
    Meyer N; Gee S; Whiskey E; Taylor D; Mijovic A; Gaughran F; Shergill S; MacCabe JH
    J Clin Psychiatry; 2015 Nov; 76(11):e1410-6. PubMed ID: 26646037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of agranulocytosis secondary to rechallenge with clozapine following severe neutropenia during previous therapy.
    Lertxundi U; Sanchez P; Hernandez R; Elizagarate E
    J Clin Psychiatry; 2011 Dec; 72(12):1659. PubMed ID: 22244024
    [No Abstract]   [Full Text] [Related]  

  • 9. Blood dyscrasias in clozapine-treated patients in Italy.
    Lambertenghi Deliliers G
    Haematologica; 2000 Mar; 85(3):233-7. PubMed ID: 10702809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comment on "lithium and clozapine rechallenge: a retrospective case analysis".
    Esposito D
    J Clin Psychiatry; 2007 Apr; 68(4):635; author reply 635. PubMed ID: 17474825
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of cytokines in clozapine-induced agranulocytosis.
    Chin-Yee I; Bezchlibnyk-Butler K; Wong L
    Can J Psychiatry; 1996 Jun; 41(5):280-4. PubMed ID: 8793147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clozapine re-challenge under the cover of Filgrastim.
    Gopalakrishnan R; Subhalakshmi TP; Kuruvilla A; Jacob KS
    J Postgrad Med; 2013; 59(1):54-5. PubMed ID: 23525060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutropenia and agranulocytosis during treatment of schizophrenia with clozapine versus other antipsychotics: an observational study in Iceland.
    Ingimarsson O; MacCabe JH; Haraldsson M; Jónsdóttir H; Sigurdsson E
    BMC Psychiatry; 2016 Dec; 16(1):441. PubMed ID: 27955666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland.
    Atkin K; Kendall F; Gould D; Freeman H; Liberman J; O'Sullivan D
    Br J Psychiatry; 1996 Oct; 169(4):483-8. PubMed ID: 8894200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lithium and clozapine-induced neutropenia/agranulocytosis.
    Blier P; Slater S; Measham T; Koch M; Wiviott G
    Int Clin Psychopharmacol; 1998 May; 13(3):137-40. PubMed ID: 9690982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sudden late onset of clozapine-induced agranulocytosis.
    Patel NC; Dorson PG; Bettinger TL
    Ann Pharmacother; 2002 Jun; 36(6):1012-5. PubMed ID: 12022904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebroventricular clozapine would be a viable treatment modality for clozapine-dependent schizophrenia patients with neutropenia.
    Alisky JM
    Med Hypotheses; 2012 Oct; 79(4):497-9. PubMed ID: 22818272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Use of Granulocyte Colony-Stimulating Factor in Clozapine Rechallenge: A Systematic Review.
    Lally J; Malik S; Krivoy A; Whiskey E; Taylor DM; Gaughran FP; Flanagan RJ; Mijovic A; MacCabe JH
    J Clin Psychopharmacol; 2017 Oct; 37(5):600-604. PubMed ID: 28817489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic benign neutropenia/agranulocytosis associated with non-clozapine antipsychotics.
    Vila-Rodriguez F; Tsang P; Barr AM
    Am J Psychiatry; 2013 Oct; 170(10):1213-4. PubMed ID: 24084822
    [No Abstract]   [Full Text] [Related]  

  • 20. Rechallenge with clozapine following leucopenia or neutropenia during previous therapy.
    Dunk LR; Annan LJ; Andrews CD
    Br J Psychiatry; 2006 Mar; 188():255-63. PubMed ID: 16507968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.